Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device

Core Viewpoint - Tempus AI, Inc. has received 510(k) clearance from the FDA for its RNA-based Tempus xR IVD device, which will enhance precision medicine and patient care through advanced RNA sequencing technology [1] Company Summary - Tempus AI, Inc. is a technology company focused on integrating AI to improve precision medicine and patient care [1] - The Tempus xR IVD device is positioned as a life sciences tool aimed at supporting drug development programs [1] Industry Summary - RNA sequencing technology is highlighted for its ability to capture extensive biological information, providing deeper insights into disease mechanisms [1]